Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Xinxiang Pharmaceutical Co. Ltd.
FDA Inspection
•Xinxiang Pharmaceutical Co. Ltd.•September 18, 2015

Xinxiang Pharmaceutical Co. Ltd. – FDA Inspection, Sep 18, 2015

Record Details

This FDA Inspection record concerns Xinxiang Pharmaceutical Co. Ltd., with an inspection on September 18, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Xinxiang Pharmaceutical Co. Ltd.
Inspection Date
September 18, 2015
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 014d7b0e-ce6b-4528-8d16-f503d0ab8f39

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
946285
FDA center
Human Drugs
Project area
Drug Quality Assurance

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Xinxiang Pharmaceutical Co. Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.